Drug Index

EPOGEN/PROCRIT

Generic: EPOETIN ALFA

Review priority: STANDARD Marketing status: Prescription

Route: SINGLE-USE
Class: General Medications
Safety profile: routine
Latest regulatory update: 30 Apr 2024, 12:00 am (UTC)

Structured Monograph

Approval overview EPOGEN/PROCRIT is listed in Drugs@FDA under application 103234 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPOETIN ALFA Form and strength VIAL; SINGLE-USE - 10,000U/ML Sponsor AMGEN Submission history Latest submission status date: 2024-04-30 00:00:00. Submission type: SUPPL.